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Background: The cognitive effects of physical exercise in patients with dementia dis-
orders or mild cognitive impairment have been examined in various studies; however 
the biochemical effects of exercise from intervention studies are largely unknown. The 
objective of this systematic review is to investigate the published results on biomarkers 
in physical exercise intervention studies in patients with MCI or dementia.
Methods: The PubMed database was searched for studies from 1976 to February 2015. 
We included intervention studies investigating the effect of physical exercise activity on 
biomarkers in patients with MCI or dementia.
Results: A total of eight studies were identified (n = 447 patients) evaluating exercise 
regimes with variable duration (single session–three sessions/week for 26 weeks) and 
intensity (light-resistance training–high-intensity aerobic exercise). Various biomarkers 
were measured before and after intervention. Seven of the eight studies found a signifi-
cant effect on their selected biomarkers with a positive effect of exercise on brain-derived 
neurotrophic factor, cholesterol, testosterone, estradiol, dehydroepiadrosterone, and 
insulin in the intervention groups compared with controls.
Conclusion: Although few studies suggest a beneficial effect on selected biomarkers, 
we need more knowledge of the biochemical effect of physical exercise in dementia or 
MCI.
Keywords: dementia, MCi, exercise intervention, biomarkers, physical activity
introduction
The prevalence of dementia is increasing, currently affecting more than 44 million people, and 
estimated affect 75 million people worldwide by 2030. Alzheimer’s disease (AD) accounts for the 
majority of dementia cases (1–3). Currently there is no cure for these disorders, and there are 
currently no effective pharmacological interventions (4, 5). Attention has therefore turned toward 
non-pharmacological approaches, including exercise, to slow the cognitive decline associated with 
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dementia (2, 6). Linking evidence from population-based cohorts 
or RCT studies with biochemical evidence will be crucial in order 
to understand how non-pharmacological interventions may 
potentially alter the course of the disease.
In epidemiological studies, retrospective cohort studies, and 
case–control studies, there is consensus that an active lifestyle in 
midlife decreases the risk of dementia in late adulthood (7, 8). 
The cognitive effects of physical exercise and an active lifestyle 
in healthy elderly subjects, and in those with MCI and dementia, 
have also been examined in various cross-sectional studies, inter-
vention studies, and prospective studies, with conflicting results 
(9–21). Almost all studies in patients with mild cognitive impair-
ment (MCI) show some effect on cognition, but recent systematic 
reviews call for caution when interpreting results in dementia due 
to limited evidence (22, 23). Lack of consensus could be due to 
differences in the study methodologies used, type of physical 
activity, or in the cognitive measures used.
Because some studies have identified a clinical effect of physi-
cal exercise, it is imperative to understand if and how exercise 
alters the pathophysiology of dementia. Such an understanding 
is necessary for the successful promotion and implementation of 
physical exercise as a part of the treatment for dementia. Our cur-
rent knowledge comes largely from animal studies. Beta-Amyloid 
(Aβ) pathology can be altered in response to exercise in a mouse 
and rat model for AD (24, 25), and brain plasticity proteins, like 
brain-derived neurotrophic factor (BDNF), can be up-regulated 
in response to physical exercise (26). Also, long-term exercise 
treatment reduces oxidative stress (OX) in the hippocampus of 
aging rats (27). In a large study of healthy elderly subjects, lower 
plasma and brain Aβ was observed in those reporting higher 
levels of physical activity (21), and similar findings has been 
found in preclinical AD subjects (28), consistent with animal 
studies suggesting that physical activity may modulate specific 
AD pathology in humans as well. However, because observational 
and cross-sectional designs cannot establish causality, we need 
randomized controlled intervention trials to understand the 
biochemical effects of exercise.
Exercise-based interventions studies in various diseases have 
clarified some of the biochemical effects of physical activity, such 
as improved metabolic homeostasis in diabetes mellitus (29), 
reduced OX in obese subjects (30), and reduced low-grade inflam-
mation in coronary artery disease (31). Thus, physical exercise 
may exert its effect through modulation of specific AD pathology 
and/or through pathological processes common to other diseases.
Therefore, the object of this study was to systematically review 
and evaluate the scientific literature regarding the biochemical 
effect of exercise in MCI and dementia disorders in intervention 
trials and furthermore to provide recommendations for future 
biochemical studies in this field. Based on the studies cited above, 
we hypothesized that physical exercise interventions would 
improve not only specific Aβ pathology, but also pathological 
processes downstream of Aβ accumulation.
Methods
This systematic review was performed according to the recom-
mendation of the Cochrane collaboration (32) and the Preferred 
Reporting Items for Systematic Review and Meta-Analysis: the 
PRISMA statement (33).
eligibility Criteria
Randomized controlled trials or clinical trials investigating the 
effect of physical exercise or activity on patients with MCI or 
dementia were selected to review. Studies must have obtained 
bio-fluid markers, regardless of whether the biomarkers were 
included as primary or secondary outcome.
Search Strategy
The following electronic database was searched: MEDLINE 
(accessed via PubMed). The database PubMed was selected 
because it contains more that 23 million citations from biomedical 
literature from MEDLINE, life science journals and online books.
The search conducted in February 2015 searched databases for 
the following MeSH terms and their English synonyms. Studies 
published from 1976 to 2015 were included.
Medline (Via Pubmed.org) was searched with the keywords 
and Boolean operators with the filter English and Human:
(“Dementia”[Majr]) AND (“Exercise”[Majr])
(“Mild Cognitive impairment”[Majr]) AND (“Exercise”[Majr])
(“Dementia”[Majr]) AND (“physical fitness”[Majr])
(“Mild Cognitive impairment”[Majr]) AND (“Physical 
fitness”[Majr])
The search was done by two authors separately (first and 
second) author. The search results are described in Figure 1.
Inclusion criteria included: original work (no review or meta-
analysis), physical activity/exercise as intervention, only full-text 
publication, and English language.
Study Selection and Data extraction
Studies were selected on the basis of the inclusion criteria listed 
above. The selected studies are listed in Table 1 and Table S1 in 
Supplementary Material. Data extraction was done by the first 
author according to the data extraction form seen in Table S2 in 
Supplementary Material, in regards to author, endpoints meas-
ured, subjects, intervention, and results found.
Results
The initial search gave 228 publications, from which 187 were 
collected for further reading and 111 of which were excluded 
due to irrelevance or because they did not meet the inclusion 
criteria on the basis of their title or abstract. From the remain-
ing 76 publications, 54 met inclusion and exclusion criteria and 
were selected for analysis. After a detailed analysis, publications 
were excluded if they did not include analysis of biomarkers. The 
excluded publications are listed in Table S1 in Supplementary 
Material. In total, eight publications remained for inclusion in 
the review. Publications included are listed in Table 1. Figure 1 
shows the flowchart of the data gathering process.
Sample Subjects
Although our MeSH term search covered all dementia diag-
noses, the majority of identified publications studied patients 
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with AD. Subjects were either from a nursing home-residing 
population (15, 35, 37) or a home-living population (34, 41, 
42). Two studies did not describe living status (38, 41).
In Table 1, mean age and mean MMSE have been listed, giving 
a general indication of the sample subjects studied. The age range 
was from 66.4 to 85.4 years. The MMSE range was from 13.9 to 
28.7. Only Baker et  al. have a population with a MMSE above 
21, which indicated that the majority of the studies have been on 
patients with moderate-to-severe dementia.
Sample Size
The numbers of subjects used in the selected studies range 
from 13 to 110 subjects. In general, the small sample sizes have 
generated little power for calculation of effect.
exercise Protocol
Four studies implemented an aerobic training program with 
low-to-high intensity (34, 35, 37, 39), three studies investigated 
the effect of a single bout of high-intensity aerobic or resistance 
training exercise (38, 41, 42) and one study investigated the 
effect of light resistance training and stretching (15). Thus, 
most studies investigated aerobic training to investigate the 
effect on biochemical biomarkers. The studies reviewed applied 
FiGURe 1 | Flowchart of the publication search and selection process.
very different training regimes, with regards to intensity, dura-
tion and frequency. Eggermont et  al. (37) applied the lowest 
intensity with a walking program at a self-selected speed, 
and they did not report any significant results on any of their 
selected biomarkers. Cheng et al. applied a light exercise pro-
gram and found that the exercise groups had a slower decline 
in their cognitive measures compared to controls. The three 
remaining aerobic exercise studies have applied a moderate-to-
high-intensity exercise program, and they found a significant 
increase in levels of their selected biomarkers, and in the cogni-
tive measures.
exercise Supervision
Five of the eight selected studies had non-supervised training 
or supervision by caregivers. Three studies had supervision by 
trainers. Two studies reported use of heart rate monitors to 
ensure that the intended exercise intensity of the exercise 
was reached. In Baker et al. (34), only some of the training 
sessions were supervised.
Cognition
Six out of these eight studies also investigated cognitive perfor-
mance (15, 34, 35, 37, 39, 41). Of these six studies, four reported 
TABLe 1 | Studies chosen for review.
Publication endpoint Subjects intervention Results on cognition Results 
biomarkers
Akishita et al. 
(15)
Cognitive markers
ADL
MMSE
Blood markers:
Estradiol
Testosterone
DHEA
DHEA sulfate
Sex hormone-
binding globulin
13 ♀ ADa
Nursing home residents
Mean age: 84.5 ± 5
Mean MMSE: 13.9 ± 1.9
N = 13, resistance training (light) + stretching 
30 min 2/weekc + 5/weekb × 12 weeks
No change in MMSE ↑ Testosterone
No change in ADL ↑ Estradiol
↑ DHEA
Baker et al. 
(34)
Cognitive markers:
Symbol-digit 
modalities
Verbal fluency
Trail B
STROOP
Task switching
Story recall
List-learning
Blood markers:
Insulin
IGF-1
Cortisol
BDNF
Platelet factor 4
Aβ42
Cholesterol
Cardio markers:
VO2 peak
29 MCIa
Home living
Mean age
Stretching 66 ± 6.0
Intervention 71 ± 7.5
Mean MMSE
Stretching 28.8 ± 1.0
Intervention 28.6 ± 1.2
n = 10, stretching (<50% HRR) 45–60 min 4/
week × 26 weeksc
n = 19, aerobic exercise (75–85% HRR) 
45–60 min 4/week × 26 weeksc
♀
Increased executive function
Increased performance in 
STROOP
Both
Increased performance in 
trail B
Gender 
difference
♀
↑ Insulin 
sensitivity
↑ Insulin
↑ Cortisol in 
control group
↑ BDNF
♂
↓ Cortisol in 
controls group
↓ BDNF
↑ IGF-1
Both
↓ Body fat
↓ Total 
Cholesterol
↑ VO2 peak
Cheng et al. 
(35)
Cognitive markers:
MMSE
Call-recall
Categorical fluency
Digit span
Blood markers:
Cholesterol
HDL
Tri-glycerides
Glucose
Genetic markers:
ApoE genotype
110 dementiaa
Nursing home residents
Mean age
Control 80.8 ± 7.2
Mahjong 81.9 ± 6.2
Tai Chi 81.8 ± 7.4
Mean MMSE
Control 18.8 ± 4.1
Mahjong 19.0 ± 3.2
Tai Chi 18.7 ± 3.9
n = 39, aerobic exercise (Tai Chi) 60 min  
3/week × 12 weeksb
n = 36, cognitive activity (Mahjong) 60 min  
3/week × 12 weeksb
Tai Chi
Slower decline in cognitive 
measures
Mahjong
Slower decline in cognitive 
measures
Non-reported
Coelho et al. 
(36)
Blood markers: 
BDNF
21 ADa
18 cognitive normal (used as 
controls)
Home living
Mean age
AD 76.3 ± 6.2
Controls 74.5 ± 4.7
Mean MMSE
AD 21.0 ± 3.9
Controls 28.0 ± 2.5
n = 39, acute aerobic exercise (85% HRR) 
17–22 min oncec
None studied Both: ↑ BDNF
Eggermont 
et al. (37)
Cognitive markers
MMSE
Face recognition
Picture recognition
Delayed word call
Digit span 
backwards
Category fluency
Letter fluency
Genetic markers
ApoE
97 dementiaa
Nursing home residents
Mean age: 85.4
Mean MMSE: 17.7
n = 51, walking 30 min 5/week × 6 weeksb No significant results reported No significant 
results 
reported
(Continued)
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Publication endpoint Subjects intervention Results on cognition Results 
biomarkers
Mancuso  
et al. (38)
Blood markers:
COX
Lactate
18 ADa
20 cognitive normal
No mention of living status
Mean age
AD 66.4 ± 8.9
Controls 63.4 ± 9.1
Mean MMSE
AD 17.4 ± 4.9
Controls, not reported
n = 38, acute resistance training (increment 
10–70% 1RM) onceb
Not studied ↑ Lactate
↓ Lactate 
recovery after 
exercise
↓ COX activity
Nascimento 
et al. (39, 41)
Cognitive markers:
MoCA
Blood markers
BDNF
TNF-α
IL-6
37 MCIa n = 35 (20 MCI, 15),aerobic exercise 
(60–80% HRR) 60 min 3/week × 16 weeksc
MCI: increased cognition Both
30 cognitive normal ↓ TNF
Home living ↓ IL
Mean age
MCI used as controls 
68.5 ± 5.9
MCI exercise 67.3 ± 5.3
Cognitive normal used as 
controls 68.1 ± 5.7
Cognitive normal exercise 
66.6 ± 7.9
Median MoCA
MCI used as controls 21
MCI exercise 20
Cognitive normal used as 
controls 27
Cognitive normal exercise 27
Segal et al. 
(41)
Cognitive marker: 
IAPS
23 aMCIa
31 cognitive normal
No mentioning of home 
status
Mean age
aMCI 71.4 ± 2.4
Cognitive normal 69 ± 2
Mean MMSE
aMCI, not reported
Cognitive normal, not 
reported
n = 26 (11a MCI, 15 controls) acute aerobic 
exercise (70% VO2max) 6 min onceb
Both: increased picture recall Both: ↑ saliva 
alpha-amylase
Saliva markers: 
alpha-amylase
ADL, activities of daily living; DHEA, dehydroepiadrosterone; AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; MCI, mild cognitive impairment; IGF-1, insulin-like 
growth factor 1; BDNF, brain-derived neurotrophic factor; Aβ40+42, beta-amyloid isoform 40 and 42; VO2 peak, peak oxygen uptake; HRR, heart rate reserve; ♀, women; ♂, men; 
MMSE, mini-mental state examination; HDL, high-density lipoprotein; COX, cytochrome c oxidase; MoCA, Montreal Cognitive Assessment; TNF-a, tumor necrosis factor alpha; IL-6, 
interleukin-6; IPAS; International Affective Picture Set.
aDiagnosed according to international guidelines.
bSupervised by caregiver, healthcare worker, or not mentioned.
cSupervised by trainer or physiotherapist.
any significant effect on the cognitive measures. Baker et al. (34) 
reported an improvement in several tests of executive function, 
but only in women, Cheng et al. (35) reported a reduced decline 
in MMSE, Nascimento et  al. (39) found an improved cognition 
measured by the Montreal Cognitive Assessment (MoCA), and 
Segal et al. (41) found a significant improved picture recall after 
exercise.
effect on Biomarkers
In total, eight studies that focused on biochemical markers 
were identified. Seven out of eight studies investigated protein 
biomarkers (15, 34, 35, 38–42), and two studies investigated the 
difference in the effect of exercise depending on the patients 
ApoE genotype (35, 37). One study also investigated markers of 
cardiovascular health (34). Table 1 summarized the biochemical 
and cognitive findings.
In seven out of eight studies, a positive relationship was found 
between their selected biomarkers and the exercise intervention. 
Only one study did not find any significant results on any of their 
selected biomarkers (37).
Coelho et  al. (36) and Segal et  al. (41), found that exercise 
resulted in a significant up-regulation in the neuroplasticity 
protein BDNF. Baker et al. (34) also measured BDNF and found 
higher levels after exercise, however only in women. Nascimento 
et al. reported BDNF as one of their end points, however they 
did not report any findings. They did, however, report decreased 
Tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) 
levels after exercise.
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TABLe 1 | Continued
Besides blood levels of BDNF, other biochemical com-
pounds in blood including cholesterol and insulin were 
analyzed. Baker et  al. (34) and Cheng et  al. (35), measured 
plasma levels of insulin and cholesterol. Cheng et al. (35) also 
measured HDL, tri-glycerides, and glucose. Only Baker et al. 
(34) reported an effect of the intervention on these biomarkers, 
namely a significant decrease in cholesterol and an increase in 
insulin sensitivity.
On a different note besides neurological markers and 
metabolic markers, Akishita et al. (15) found that exercise had a 
significant up-regulating effect on selected sex hormones (testos-
terone, estradiol, and DEHA) in women. Segal et al. (41) found an 
increase in salivary alpha-amylase (sAA), an indirect measure of 
endogenous norepinephrine (NE), after a single session of high-
intensity exercise (70% HRR). Mancuso et  al. (38) found that 
lactate increased after exercise, and that platelet mitochondria 
COX activity was decreased.
We did not find any intervention studies that investigated the 
effect of exercise on established diagnostic markers for dementia 
disease, such as Aβ, tau, p-tau, and α-synuclein.
Discussion
Physical exercise as a non-pharmacological treatment for medi-
cal disease has proven beneficial for reducing the risk for many 
diseases including stroke, high blood pressure, and mental 
disorders like chronic stress and depression (43). However, 
compared to our understanding or physical exercise’s impact on 
cardiovascular health and general fitness, our understanding of 
physical exercise’s impact on cognitive health is still very much 
in its infancy. An impact of physical exercise on quality of life 
and activity of daily living in patients with dementia has been 
established; however evidence of the molecular effects is not 
clear.
The objective of this study was to conduct a systematic review 
to identify and evaluate the scientific literature published on 
the effect of an exercise intervention in dementia, in regards to 
relevant biomarkers.
Biochemical evidence of the effects of exercise
Insulin and diabetes have been connected to an increased risk of 
developing AD and cognitive impairment (44, 45). Two of the 
reviewed studies measured insulin sensitivity or glucose control. 
Baker et al. (34) found increased insulin sensitivity and increased 
insulin in the exercise group, however only in women. Cheng 
et al. (35) measured blood glucose levels, but they did not find 
any significant result.
Mancuso et al. (38) investigated the reactive oxygen species 
(ROS) generation and OX, measured via COX activity and lactate 
production in platelets. ROS and OX are thought to be involved 
in AD through the neurotoxicity of amyloid build up, metabolic 
impairments and free-radical production in mitochondria (46, 
47). To investigate the metabolic contribution of mitochondrial 
impairment, COX activity and lactate production was measured 
before and after an exercise intervention. At baseline, the AD 
groups displayed higher levels of lactate and significantly lower 
activity of COX, compared to aged match cognitive normal 
individuals. This increased level of lactate in AD patients was 
unchanged throughout the exercise intervention, indicating 
mitochondrial impairment in AD. The exercise intervention did 
not alter COX activity, indicating that exercise might not be able 
to influence the mitochondrial electron transport chain (ETC). 
However, since Mancuso et al. (38) did not find any correlation 
with cognitive elements, such as MMSE, mitochondrial impair-
ment might be an angle to study the pathology of AD, and not so 
much a way to improve cognitive decline.
Nascimento et al. (39, 41) investigated the influence of exercise 
on inflammation markers in MCI and cognitively normal subjects 
and found decreased levels of the pro-inflammatory cytokines, 
TNF-α and IL-6. Inflammation is a known factor in neurodegen-
erative diseases (48–50). Both pro-inflammatory cytokines (e.g., 
IL-6) and anti-inflammatory cytokines (e.g., IL-10 and IL-18) 
have been found to be increased in AD (51), and wherein it is 
speculated that an increased inflammatory response negatively 
contributes to neurodegeneration in AD (50). Several studies 
have shown that inflammation is directly influenced by physical 
activity, which down-regulates pro-inflammatory reactions in the 
brain (52). For further insight into the pathology of neuroinflam-
mation, it might be beneficial to measure a variety of factors, both 
pro-inflammatory and anti-inflammatory.
Three of eight identified studies have focused on BDNF, 
all of which found an increase in BDNF after exercise. Lower 
levels of brain tissue BDNF have been seen in patients with AD 
compared to healthy controls (26, 53). The exercise-induced 
BDNF increase seen in the studies in this review has also been 
reported in animal studies, where brain levels of BDNF were 
increased after exercise (26), and in an intervention study in 
young healthy men, where plasma BDNF was increased with 
exercise. In order to achieve a more precise measurement of 
neuronal BDNF without the systemic component, BDNF levels 
in CSF could be assessed.
Alongside BDNF, Akishita et  al. (15) measured increased 
levels of female sex hormones after exercise. Lower levels of 
sex hormones have previously been shown to increase the risk 
of AD (54). Exercise has been found to increase sex hormones 
and sex hormone-binding globulin in post-menstrual women 
(55–57). One could therefore speculate that an increase in sex 
hormones is beneficial to the cognitive performance in patients 
already diagnosed with AD. In the study by Akishita et al. (15), 
there was no effect on ADL or cognition, and the up-regulating 
effect of exercise on sex hormones was lost after 3  months 
post-exercise.
Pharmacological evidence established that NE is involved in 
memory modulation, and can be regulated by exercise (58–60). 
This makes NE modulation by exercise an ideal target for memory 
modulation in patients with cognitive impairments. Segal et  al. 
(41) studied this relationship with a single bout of high-intensity 
exercise in patients with aMCI. The cognitive performance was 
investigated with picture recall before and after exercise, and NE 
was measured indirectly via sAA. They found that performance in 
picture recall was significantly improved in the exercise cognitive 
normal control group as well in the exercise aMCI groups, and not 
in the corresponding non-exercise groups. Furthermore, sAA levels 
were equally increased in both exercise groups (cognitive normal 
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and aMCI). When it comes to dementia diseases, like AD with more 
advanced neurodegeneration, it is unknown if exercise is able to up-
regulate NE, so further studies are needed. In addition, the potential 
harms of recurring acute increases in NE need to be investigated.
None of the review studies in this review focused their 
attention on already previously established markers of neu-
rodegenerative disease. Baker et al. (61) has studied the effect 
of a diet intervention with or without high-intensity physical 
activity, and its effect on CSF levels of the amyloidogenic peptide 
Aβ42. The main outcome was that patients with MCI subjected 
to a modulated diet, and who had a high-intensity physically 
active lifestyle, had higher levels of CSF Aβ42, than those without 
an active lifestyle. Furthermore, brain levels of Aβ42 have been 
shown in animal studies to be reduced in response to physical 
exercise (62). Aβ42 therefore appears to be a physiologically 
relevant biomarker that was not measured in any of the included 
studies likely due to difficulty of including CSF measures in 
study design, attributable to the discomfort of lumbar puncture.
Normal Aging
In previous studies on the effect of exercise in a population of 
healthy elderly individuals, a decrease in the metabolic biomarkers 
of cholesterol, HDL, and leptin (63) was described. Furthermore, 
the exercise group showed increased glucose sensitivity after 
intervention, compared to controls (63). Aging is connected with 
chronic low-grade inflammation, increased risk for disease, poor 
physical function and mortality (64). Exercise has been shown 
to decrease the levels of circulating inflammatory cytokines (65). 
The expected effects of exercise on biomarkers of metabolism and 
inflammation are similar between normal aging individuals and 
patients with dementia. In the study by Nascimento et  al. (39, 
41), where aged matched cognitive normal controls were stud-
ied, the effect of exercise on the inflammation biomarkers were 
not specific to either the dementia group or the control group. 
However, only the MCI group showed improved cognition. This 
could indicate a link between cognitive measures and alterations 
in the inflammation profile. One could speculate that the lack 
of effect on cognition seen in the control group could be due to 
the scale chosen for measuring cognition (MoCA). MoCA may 
not be sensitive enough to quantify cognition in a group that 
already performs well cognitively, as this group had high MoCA 
scores even before intervention, and thereby improvement in the 
controls group will not be detected.
BDNF has previously been investigated not only for its brain 
plasticity modulating effect in dementia patients, but also in sub-
jects with depression (66) and in animal studies, high-intensity 
exercise has a modulating effect on BDNF (26). Studies have 
found that BDNF levels decline with age, and it has been shown 
to be associated with memory deficits (67). An up-regulation of 
BDNF would therefore be beneficial, and maybe act as a protect-
ing factor against dementia and other memory deficiencies.
Genetic Risk Factors
The effect of the known risk factor for AD, ApoE (68), was found 
not to have an effect for the outcome on biomarkers after an 
exercise intervention. Previous studies have indicated that that 
outcome of an exercise intervention could be ApoE genotype 
dependent (69). However, neither Eggermont et  al. (37) nor 
Cheng et al. (35), found any significant difference in effect accord-
ing to ApoE genotype.
A possibility to further explore the ApoE effect on AD could 
be to investigate the gene product of ApoE, the protein apoE. A 
recent study has indicated that low levels of apoE increases risk 
of AD (70). Currently there are no plasma markers for AD, and 
perhaps apoE may have the potential to be a ground-breaking 
new risk factor for AD.
exercise intervention
In regards to the exercise protocol, most studies applied an 
aerobic training, like walking, to investigate the effect on bio-
chemical markers. The studies reviewed have applied varying 
training regimes, durations, and frequencies. This makes a direct 
comparison difficult. However, most of the studies applying a 
moderate-to-high-intensity aerobic exercise protocol, have found 
a significant effect on biomarkers, while low-intensity protocols 
did not show significant effects. This could indicate that the level 
of intensity of the aerobic exercise is important for achieving an 
effect of an exercise intervention.
The level of supervision for protocol adherence and intensity 
varied greatly among the reviewed studies. Overall supervision 
is necessary to ensure general adherence to the program and 
that exercise intensity is maintained, especially when it comes to 
moderate-to-high-intensity exercise, where the physical demands 
on the patients are far greater. For example, supervised training 
sessions with professional trainers and equipment, such as a pulse 
watch, can be used.
Cognition
Another caveat worth considering is whether the effect of 
physical exercise on cognition is caused by measurable changes 
in biomarkers that reflect the pathophysiology of the disorder or 
whether exercise improves cognition through general improve-
ment of brain function through other mechanisms. These could 
include up-regulation of neurotransmitters relevant for cogni-
tion, such as NE or increase in vascular endothelial growth factor 
(71). This remains to be determined.
Biomarkers are the main outcome assessed in this review 
article, but when studying dementias, cognitive measures have 
to be taken into account. It is unclear whether lack of cognitive 
assessment as a measured outcome is due to negative findings or 
that cognition went untested. Although a change in a biochemi-
cal markers with physical exercise does not imply a therapeutic 
effect on symptomatology, an objectively measurable effect on a 
relevant pathophysiological biochemical parameter will support 
the importance of an implementation of physical exercise as part 
of the treatment for dementia.
Recommendations for Sampling and Analysis
Of all the studies that have been conducted on exercise in patients 
with dementia disease or cognitive impairment, only eight studies 
have included biomarkers as a part of their assessment. However, 
the effect on functional activity and quality of life are relevant to 
the patient and caregiver, useful biochemical measures of these 
effects are still lacking.
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